Callan Family Office’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$435K Sell
2,060
-13
-0.6% -$2.39K 0.01% 860
2026
Q1
$331K Sell
2,073
-224
-10% -$34.4K 0.01% 898
2025
Q4
$315K Buy
+2,297
New +$297K 0.01% 916

Other funds holding NHC

Callan Family Office's NHC Position: Q2 2026 in Review

Callan Family Office reduced its National Healthcare (NHC) stake by 0.63% in Q2 2026, selling an estimated $2.39K and leaving 2,060 shares worth $435K. The position accounts for 0.01% of the portfolio, ranked #860.

Callan Family Office first reported a position in NHC in Q4 2025 and has held it in 3 quarters since. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Callan Family Office held 2,060 shares of National Healthcare worth $435K as of Q2 2026.
  • Callan Family Office sold 13 National Healthcare shares in Q2 2026, an estimated $2.39K.
  • National Healthcare made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #860 holding.
  • Callan Family Office first reported a position in National Healthcare in Q4 2025 and has held it in 3 quarters since.
  • 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.